Journal article

Psychiatric-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: A phase 3, randomized, double-blind, multicentre, parallel-group, placebo- and active-controlled, dose-optimized study in Europe

ML Lecendreux, RW Dittmann, M Gasior, T Banaschewski, R Civil, R Bloomfield, L Squires, DR Coghill

Neuropsychiatrie de l'Enfance et de l'Adolescence | Elsevier BV | Published : 2012

DOI: 10.1016/j.neurenf.2012.04.685

University of Melbourne Researchers

Citation metrics

1Dimensions

Keywords

5202 Biological Psychology
Mental Health
6.1 Pharmaceuticals
Clinical Trials and Supportive Activities
Attention Deficit Hyperactivity Disorder (adhd)
32 Biomedical and Clinical Sciences
Brain Disorders
52 Psychology
Pediatric Research Initiative
Clinical Research
Behavioral and Social Science